MarketResearch.biz delivers in-depth insights on the global obesity surgery devices market in its upcoming report titled, “cTrends, Applications, Analysis, Growth, and Forecast: 2018 to 2027”. The global obesity surgery devices market is estimated to register a CAGR of XXX% in terms of value during forecast period 2018–2027. The report offers in-depth insights, revenue details, and other vital information regarding the target market, and the various trends, drivers, restraints, opportunities, and threats till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global obesity surgery devices market report has been segmented on the basis of surgical procedure, device type and region.
Obesity is a chronic condition that is increasing in all age groups, and is considered as global epidemic. Obesity results from an imbalance between energy input and energy expenditure. However, weight gain is multifactorial and may be due to identifiable and specific genetic, damage to the hypothalamus, drugs or life changing events. Obesity itself is a health hazard as it impacts the heart, lungs, muscles, and bones of the body. In addition, obesity is a known risk factor to develop diabetes, heart disease and high blood pressure. There are several different types of weight loss surgery that are done on the stomach, intestine or both. According to World Health Organization, obesity is one of leading preventable cause of the death. In 2016, WHO data showed that about 15% of the entire world populations were obese.
Increasing prevalence of obesity is leading to high demand for obesity surgeries which in turn is boosting growth the obesity surgery devices market. In addition, rising awareness about surgery in obese population, changing lifestyles, increasing prevalence of obesity associated chronic diseases, growing awareness about obesity related complexities, lack of physical activity due to a sedentary lifestyle, changing modes of transportation, excessive consumption of fatty food are factors fuelling demand for obesity surgery devices. High cost of obesity surgery, some risk of infection and other complications associated with obesity surgery are expected to hinder growth of the global obesity surgery devices market.
Many organizations are conducting obesity awareness programs to increase awareness regarding various treatment options and other options such as proper diet, exercise, and bariatric surgery available for obesity. Recent introduction of the Treat and Reduce Obesity Act 2017, will increase range of obesity treatments that Medicare covers. According to data published by the Obesity Society in 2016, only 26% of the obese population in the U.S. is covered under the Medicare, Medicaid and essential health benefit plans under the Affordable Care Act (ACA). These insurance covers help obese patients to select for best effective obesity surgical procedures creating demand for surgical products in the obesity surgery devices market.
North America market is estimated to dominate the global market for obesity surgery devices, owing to increasing demand for minimally invasive procedures for reducing obesity, high expenditure on healthcare and increasing number of obese population in countries in the region. The Centers for Disease Control and Prevention (CDC) estimates that around 42% of Americans are likely to be obese by 2030, with approximately 32 million obese adults in the U.S., by 2030. Asia Pacific is the emerging market for obesity surgery devices, due to rising prevalence of obesity, and booming medical tourism in countries in the region.
Global Obesity Surgery Devices Market Segmentation:
Segmentation on the basis of surgical procedure:
- Gastric Bypass Surgery
- Sleeve Gastrectomy Surgery
- Gastric Banding Surgery
- Others (Including, biliopancreatic diversion with duodenal switch, vertical-banded gastroplasty, long-limb gastric bypass)
Segmentation on the basis of device type:
- Adjustable Gastric Bands
- Intragastric Balloons
- Clip Appliers
- Surgical Staples
- Others (including suction instruments, endoscopic suturing instruments etc.)
Segmentation on the basis of region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn
- Johnson & Johnson
- Mediflex Surgical Product
- TransEnterix, Inc.
- Aspire Bariatrics, Inc.
- Apollo Endosurgery, Inc.
- Cousin Biotech
- ReShape Lifesciences Inc.
- Allergan, Inc.
- Medtronic, Inc.
- USGI Medical Inc.
Request for TOC
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
Request for Customization
Don't just take our word. We are trusted by these great companies!